BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 35567091)

  • 61. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development, optimization, and characterization of a novel tea tree oil nanogel using response surface methodology.
    Sinha P; Srivastava S; Mishra N; Singh DK; Luqman S; Chanda D; Yadav NP
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1434-45. PubMed ID: 26821208
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chitosan-Coated 5-Fluorouracil Incorporated Emulsions as Transdermal Drug Delivery Matrices.
    Khan TA; Azad AK; Fuloria S; Nawaz A; Subramaniyan V; Akhlaq M; Safdar M; Sathasivam KV; Sekar M; Porwal O; Meenakshi DU; Malviya R; Miret MM; Mendiratta A; Fuloria NK
    Polymers (Basel); 2021 Sep; 13(19):. PubMed ID: 34641162
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Boosting transdermal delivery of atorvastatin calcium via o/w nanoemulsifying system: Two-step optimization, ex vivo and in vivo evaluation.
    Shaker DS; Ishak RAH; Elhuoni MA; Ghoneim AM
    Int J Pharm; 2020 Mar; 578():119073. PubMed ID: 31982556
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development of Curcumin loaded chitosan polymer based nanoemulsion gel: In vitro, ex vivo evaluation and in vivo wound healing studies.
    Thomas L; Zakir F; Mirza MA; Anwer MK; Ahmad FJ; Iqbal Z
    Int J Biol Macromol; 2017 Aug; 101():569-579. PubMed ID: 28322948
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Formulation design and in vitro ex vivo evaluation of transdermal patches of Cinnarizine.
    Yamsani VV; Mudulaghar MK; Afreen S; Wajid S; Ravula SK; Babelghaith SD
    Pak J Pharm Sci; 2017 Nov; 30(6):2075-2083. PubMed ID: 29175776
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
    Zhao X; Sun Y; Li Z
    Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
    Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
    J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preparation, In-vitro, Ex-vivo, and Pharmacokinetic Study of Lasmiditan as Intranasal Nanoemulsion-based In Situ Gel.
    Jaber SH; Rajab NA
    Pharm Nanotechnol; 2024 Jan; ():. PubMed ID: 38173066
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fabrication of Tizanidine Loaded Patches Using Flaxseed Oil and Coriander Oil as a Penetration Enhancer for Transdermal Delivery.
    Akhlaq M; Azad AK; Fuloria S; Meenakshi DU; Raza S; Safdar M; Nawaz A; Subramaniyan V; Sekar M; Sathasivam KV; Wu YS; Miret MM; Fuloria NK
    Polymers (Basel); 2021 Dec; 13(23):. PubMed ID: 34883720
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery.
    Akhtar N; Arkvanshi S; Bhattacharya SS; Verma A; Pathak K
    J Liposome Res; 2015 Sep; 25(3):191-201. PubMed ID: 25357198
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesic.
    Singh S; Vardhan H; Kotla NG; Maddiboyina B; Sharma D; Webster TJ
    Int J Nanomedicine; 2016; 11():1475-82. PubMed ID: 27114707
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enhanced skin permeation of glabridin using eutectic mixture-based nanoemulsion.
    Liu C; Hu J; Sui H; Zhao Q; Zhang X; Wang W
    Drug Deliv Transl Res; 2017 Apr; 7(2):325-332. PubMed ID: 28188607
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Mar; 92(6-7):383-92. PubMed ID: 23353874
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.
    Nasiri MI; Vora LK; Ershaid JA; Peng K; Tekko IA; Donnelly RF
    Drug Deliv Transl Res; 2022 Apr; 12(4):881-896. PubMed ID: 34939170
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Flurbiprofen loaded ethosomes - transdermal delivery of anti-inflammatory effect in rat model.
    Paliwal S; Tilak A; Sharma J; Dave V; Sharma S; Yadav R; Patel S; Verma K; Tak K
    Lipids Health Dis; 2019 Jun; 18(1):133. PubMed ID: 31170970
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics.
    Yang M; Gu Y; Yang D; Tang X; Liu J
    J Nanobiotechnology; 2017 Dec; 15(1):88. PubMed ID: 29202753
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin - pharmacodynamic and antioxidant studies.
    Sharma S; Sahni JK; Ali J; Baboota S
    Drug Deliv; 2015; 22(4):541-51. PubMed ID: 24625264
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.